Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: nab who wrote (2920)	7/31/1999 7:28:00 PM
From: BARRY ALLEN	Read Replies (3) \| Respond to of 4140

James P. McCulley. – M.D. Chair (Voting Member) Professor and Chairman of the Department of Ophthalmology, University of Texas Southwestern Medical School CLAO pharmacy session highlights usage, new drug Topical antimicrobials, cyclosporine A, new corticosteroid are discussion topics >>>Dr. McCulley said he has no financial interest in any of the drugs mentioned, but that Alcon has given his department a research grant to support a clinical coordinator.<<< Ophthalmology Times, 05-15-1998, pp 14. Conflict of interest?? Nah.....just a little schmear for being a great professor. Maybe someone should check if any of the Refractive Surgery companies gave any research grants to any of the ODP's academic institutions! *************************** James P. McCulley, listed on VISX 'Find A Doctor' search no less than three times! Three different practices in Texas! visx.com